A decontamination device (1) for decontaminating products in the form of consumer goods and/or consumer good packaging having consumer goods located therein prior to supplying the consumer goods into an isolator, the decontamination device comprising several decontamination chambers (3, 4, 5, 6) each having a closable inlet opening (9) and a closable outlet opening (10), and each comprising application means (7) for applying a decontamination agent, to the decontamination chambers (3, 4, 5, 6), and the decontamination device (1) comprising a distributor chamber (11) disposed upstream of the decontamination chambers (3, 4, 5, 6) and having a supply opening (24) for products to be decontaminated, the distributor chamber (11) comprising distributor means (15) for distributing the products to the different decontamination chambers (3, 4, 5, 6), and the decontamination device (1) comprising a discharge chamber (12) disposed downstream of the decontamination chambers (3, 4, 5, 6) and having a discharge opening (2) and comprising transport means (16) for transporting the decontaminated products out of the decontamination chambers (3, 4, 5, 6), the distributor chamber (11) and/or the discharge chamber (12) being assigned means (17) for reducing a decontamination agent concentration by means of which the decontamination agent is conveyed through a catalytic converter in air circulation mode and/or decontamination agent is displaced by supplying fresh air.

Methods, apparatuses, systems, and implementations for inductive heating of a foreign metallic implant are disclosed. A foreign metallic implant may be heated via AMF pulses to ensure that the surface of the foreign metallic implant heats in a uniform manner. As the surface temperature of the foreign metallic implant rises, acoustic signatures may be detected by acoustic sensors that may indicate that tissue may be heating to an undesirable level approaching a boiling point. Once these acoustic signatures are detected, the AMF pulses may be shut off for a time period to allow the surface temperature of the implant to cool before applying additional AMF pulses. In this manner, the surface temperature of a foreign metallic implant may be uniformly heated to a temperature adequate to treat bacterial biofilm buildup on the surface of the foreign metallic implant without damaging surrounding tissue. The AMF pulse treatment can be combined with an antibacterial/antimicrobial treatment regimen to reduce the time and/or antibacterial dosage amount needed to remove the biofilm from the metallic implant.

In a first aspect, the present invention relates to a process for producing a stable, injectable solution with low content of noradrenaline, which includes dissolving noradrenaline and optionally an excipient in deoxygenated or degassed water, filtrating the resulting noradrenaline solution in a nitrogen current, distributing the solution in a nitrogen current, and sterilization, preferably hot. The invention further provides a stable, injectable solution with low content of noradrenaline, substantially free of anti-oxidizing and preservative agents, as well as uses thereof in the medical and pharmaceutical fields.

An image forming apparatus includes: sheet feeding trays; an image forming part that includes a fixing part and forms an image on a sheet fed from each of the sheet feeding trays based on a print job; and an acquisition part that acquires information indicating “presence” or “absence” of a possible carrier having a possibility of virus infection in a region where an apparatus main body is installed; and a hardware processor that is able to select an operation mode of the print job from a normal mode and a virus removal mode, and sets an operation mode of the print job to the virus removal mode, wherein in the virus removal mode, a fixing temperature of the fixing part is set to a predetermined temperature, and a heating time for the sheet in the fixing part is made longer than a heating time in the normal mode.

The present invention provides systems and methods for treating agricultural particulates, such as buds, Cannabis buds, herbs, leaves, and the like, with a treatment agent, such as steam, as the agricultural products move forward along a pathway created by a conveyer, in a chamber, enclosed by an aligned ceiling and floor, and oppositely disposed lateral walls. The exposure times to the steam, created by the intervals and lengths in which steam enters the chamber results in the elimination (destruction) and/or neutralization of the pathogens on the agricultural particulates, while the agricultural particulates remain undamaged and active.

Methods of sterilizing biologics or biological components are disclosed wherein the biologic or biological component in solution or suspension form are formed using an annealing step during freeze drying so that a porous solid matrix which allows penetration of a sterilizing gas such as EtO to pass through. The annealing process decreases the particle size of lyophilized material as compared to other methods and provides a more uniform cake that is easy to reconstitute. In addition, the resulting lyophilized material made with the annealing step allows better penetration of the sterilizing gas for more effective and uniform sterilization of the material.

A container or load basket (80, 90) constructed for addressing thermal stratification of a product in the container/load basket and addressing thermal stratification of the processing medium during high pressure processing with a pressurized processing medium. The container includes an upper section (86, 96) forming a volume for receiving the product to be processed and a truncated lower section forming the bottom of the container. The bottom of the container is defined by a floor or partition (84, 92) extending across the lower portion of the container.The floor or partition can be constructed from the same material from which the upper section of the container is formed or a material that is more adiabatically active than the material from which the upper section of the container is formed.

Disclosed herein are soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. Some of the hyaluronic acid-based compositions can include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. Compared to conventional compositions that include lidocaine, some of the hyaluronic acid-based compositions disclosed herein can have an enhanced stability, for example, when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such compositions are also provided.

A treatment chamber, preferably a medical treatment chamber for treating articles, preferably medical articles, devices and equipment, more particularly within the scope of sterilizing processes, including a treatment compartment which is surrounded by a lower wall element, a plurality of lateral wall elements and an upper wall element, wherein the treatment compartment is hermetically sealed or sealable for generating a desired internal pressure therein and can be temperature-controlled for generating a desired internal temperature therein, wherein at least one of the wall elements is formed of at least one hollow chamber section is disclosed.

In a first aspect, the present invention relates to a process for producing a stable, injectable solution with low content of noradrenaline, which includes dissolving noradrenaline and optionally an excipient in deoxygenated or degassed water, filtrating the resulting noradrenaline solution in a nitrogen current, distributing the solution in a nitrogen current, and sterilization, preferably hot. The invention further provides a stable, injectable solution with low content of noradrenaline, substantially free of anti-oxidizing and preservative agents, as well as uses thereof in the medical and pharmaceutical fields.